AdvaMed on price transparency
This article was originally published in The Gray Sheet
Executive Summary
Healthcare value measures should incorporate clinical outcomes of entire episodes of care and should not be based solely on cost or "artificially fixed time periods," according to a 1policy position passed by AdvaMed's board Dec. 14. The trade group adds that measures should risk-adjust for patient complexity, place minimal burdens on providers, and ensure continued access to the full array of medical technologies. The position follows an August order by President Bush requiring four government agencies to begin transparency initiatives in January that will make price and quality of care data publicly available (2"The Gray Sheet" Aug. 28, 2006, p. 16)...